Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 373

1.

Early deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment.

Sabatino F, Sarnicola E, Sarnicola C, Tosi GM, Perri P, Sarnicola V; Medscape.

Eye (Lond). 2017 Dec;31(12):1639-1646. doi: 10.1038/eye.2017.228. Epub 2017 Dec 1.

PMID:
29192684
2.

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells.

Bou Nasser Eddine F, Ramia E, Tosi G, Forlani G, Accolla RS.

Oncoimmunology. 2017 Jul 31;6(11):e1356149. doi: 10.1080/2162402X.2017.1356149. eCollection 2017. Review.

PMID:
29147609
3.

Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders.

Duskey JT, Belletti D, Pederzoli F, Vandelli MA, Forni F, Ruozi B, Tosi G.

Int Rev Neurobiol. 2017;137:1-28. doi: 10.1016/bs.irn.2017.08.006. Epub 2017 Oct 16.

PMID:
29132540
4.

Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.

Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2017 Nov 3:1-6. doi: 10.1080/09273948.2017.1391297. [Epub ahead of print]

PMID:
29099660
5.

Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics. 511 (1) (2016) 331-340).

Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Cappello V, Vandelli MA, Forni F, Tosi G, Ruozi B.

Int J Pharm. 2017 Nov 25;533(1):321. doi: 10.1016/j.ijpharm.2017.10.019. No abstract available.

PMID:
29056147
6.

Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2017 Oct 5:1-6. doi: 10.1080/09273948.2017.1351573. [Epub ahead of print]

PMID:
28981395
7.

Corrigendum to "New vaccination strategies in liver cancer" [Cytokine Growth Factor Rev. 36 (2017) 125-129].

Buonaguro L; HEPAVAC Consortium.

Cytokine Growth Factor Rev. 2017 Sep 12. pii: S1359-6101(17)30149-1. doi: 10.1016/j.cytogfr.2017.09.001. [Epub ahead of print] No abstract available.

PMID:
28918939
8.

Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.

Galvagni F, Nardi F, Spiga O, Trezza A, Tarticchio G, Pellicani R, Andreuzzi E, Caldi E, Toti P, Tosi GM, Santucci A, Iozzo RV, Mongiat M, Orlandini M.

Matrix Biol. 2017 Dec;64:112-127. doi: 10.1016/j.matbio.2017.08.003. Epub 2017 Sep 11.

PMID:
28912033
9.

Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales.

Franzo G, Massi P, Tucciarone CM, Barbieri I, Tosi G, Fiorentini L, Ciccozzi M, Lavazza A, Cecchinato M, Moreno A.

PLoS One. 2017 Sep 7;12(9):e0184401. doi: 10.1371/journal.pone.0184401. eCollection 2017.

10.

Silicon quantum processor with robust long-distance qubit couplings.

Tosi G, Mohiyaddin FA, Schmitt V, Tenberg S, Rahman R, Klimeck G, Morello A.

Nat Commun. 2017 Sep 6;8(1):450. doi: 10.1038/s41467-017-00378-x.

11.

Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study.

Fabiani C, Sota J, Vitale A, Rigante D, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Gentileschi S, Capozzoli M, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Br J Ophthalmol. 2017 Aug 26. pii: bjophthalmol-2017-310733. doi: 10.1136/bjophthalmol-2017-310733. [Epub ahead of print]

PMID:
28844047
12.

Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Rheumatol Int. 2017 Jul 27. doi: 10.1007/s00296-017-3775-5. [Epub ahead of print] Review.

PMID:
28752230
13.

PROPHYLACTIC PREOPERATIVE LASER RETINOPEXY DOES NOT REDUCE THE OCCURRENCE OF RHEGMATOGENOUS RETINAL COMPLICATIONS IN MACULAR SURGERY.

Garg A, Chang JS, Tosi GM, Esposti P, Chen RW, Horowitz J, Hoang QV, Schiff WM, Barile GR, Chang S.

Retina. 2017 Jul 21. doi: 10.1097/IAE.0000000000001780. [Epub ahead of print]

PMID:
28737533
14.

Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach.

Belletti D, Riva G, Luppi M, Tosi G, Forni F, Vandelli MA, Ruozi B, Pederzoli F.

Eur J Pharm Sci. 2017 Sep 30;107:230-239. doi: 10.1016/j.ejps.2017.07.020. Epub 2017 Jul 18.

PMID:
28728978
15.

Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Fabiani C, Vitale A, Orlando I, Sota J, Capozzoli M, Franceschini R, Galeazzi M, Tosi GM, Frediani B, Cantarini L.

Intern Emerg Med. 2017 Oct;12(7):947-955. doi: 10.1007/s11739-017-1691-z. Epub 2017 Jun 15.

PMID:
28620840
16.

Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.

Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Favale RA, Fusco F, Franceschini R, Frediani B, Iannone F, Galeazzi M, Tosi GM, Cantarini L.

J Ocul Pharmacol Ther. 2017 Sep;33(7):549-555. doi: 10.1089/jop.2017.0034. Epub 2017 May 30.

PMID:
28557602
17.

Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.

Forlani G, Tosi G, Turrini F, Poli G, Vicenzi E, Accolla RS.

Front Immunol. 2017 May 15;8:564. doi: 10.3389/fimmu.2017.00564. eCollection 2017.

18.

IL-6 blockade in the management of non-infectious uveitis.

Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.

Clin Rheumatol. 2017 Jul;36(7):1459-1469. doi: 10.1007/s10067-017-3672-z. Epub 2017 May 20.

PMID:
28528519
19.

Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.

Barbara R, Belletti D, Pederzoli F, Masoni M, Keller J, Ballestrazzi A, Vandelli MA, Tosi G, Grabrucker AM.

Int J Pharm. 2017 Jun 30;526(1-2):413-424. doi: 10.1016/j.ijpharm.2017.05.015. Epub 2017 May 8.

PMID:
28495580
20.

Protein corona and nanoparticles: how can we investigate on?

Pederzoli F, Tosi G, Vandelli MA, Belletti D, Forni F, Ruozi B.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6). doi: 10.1002/wnan.1467. Epub 2017 Mar 15. Review.

PMID:
28296346

Supplemental Content

Loading ...
Support Center